FDA UPDATED PEPTIDES APRIL 15, 2026 Most people are already getting this wrong. Today, the FDA updated its 503A compounding categories and removed several peptides from the high risk (Category 2) BPC 157 TB 500 Thrive Bio Lab Buy BPC 157 Peptide 99%+ Pure BPC 157 for Research FDA Peptide Reclassification 2026: What Researchers Want FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of A Note on Peptides by Shantanu Out of Singapore